Across the three published human trials, urolithin A caused no serious adverse events at 250 to 1,000 mg per day. The complaints that did appear were mild and digestive — loose stools, nausea, stomach discomfort — at rates close to placebo. For US buyers the honest limits are duration, untested groups, and what the label actually contains.
That is a short answer to a question most supplement pages dodge. The longer answer is more useful, because "well tolerated" in a four-month trial of 66 people is not the same claim as "safe for anyone, indefinitely." Below are the five things the published record supports, in the order that matters to somebody deciding whether to start.
Mild Digestive Upset Is the Only Complaint That Recurs
The side effects reported across urolithin A trials cluster in one place: the gut. Participants described loose stools, mild nausea, and vague abdominal discomfort, usually in the first days of taking it. None of the trials found these at rates meaningfully above placebo.
The first-in-human study (Andreux et al., Nature Metabolism, 2019) tested single doses up to 2,000 mg and daily doses of 250, 500 and 1,000 mg for four weeks in healthy older adults. It reported the compound as safe and well tolerated at every level tested, with no dose-limiting toxicity.
This matches what the molecule is. Urolithin A is a postbiotic — a compound your gut bacteria make from the ellagitannins in pomegranates, walnuts and some berries (Tomás-Barberán et al., Molecular Nutrition & Food Research, 2017). Taking it as a capsule delivers something your digestive tract already handles, which is a plausible reason the tolerability signal is quiet. Taking it with food is the standard way people reduce that first-week rumble.
No Serious Adverse Events at Any Dose Tested
Three randomised, placebo-controlled human trials have been published. None of them reported a serious adverse event attributed to urolithin A.
The four-month trial in middle-aged adults (Singh et al., Cell Reports Medicine, 2022) ran 500 mg and 1,000 mg daily against placebo in 88 people aged 40 to 64. The four-month trial in older adults (Liu et al., JAMA Network Open, 2022) ran 1,000 mg daily in 66 people aged 65 to 90. Both described the compound as well tolerated, with adverse events distributed similarly between the supplement and placebo arms.
Worth saying plainly, because supplement marketing rarely does: both of those trials missed their primary endpoint. Neither produced a statistically significant improvement on the main measure it was designed around. The benefit signals that did appear — muscle strength, muscle endurance, mitochondrial biomarkers — were secondary. That is a limitation on the efficacy side, not the safety side, and the full benefits picture is covered separately.
Supporting the human data, a preclinical toxicology package (Heilman et al., Food and Chemical Toxicology, 2017) reported no genotoxicity and established a no-observed-adverse-effect level in a 90-day repeated-dose animal study.
Four Months Is the Longest Anyone Has Been Studied
The single most important limitation is duration. The longest published urolithin A trials ran four months. Nobody has published a two-year human safety dataset, and a supplement marketed for healthy aging is one people expect to take for years.
That gap is not evidence of harm. It is an absence of evidence, and the two are different things — but a page that tells you urolithin A is "proven safe long-term" is telling you something the literature does not support. What can be said is narrower: at 500 to 1,000 mg daily, for up to four months, in adults aged 40 to 90, no serious safety signal appeared.
A practical reading of that: the tested window is a reasonable window to work in. Take it for a defined stretch, notice what changes, and reassess rather than defaulting into an indefinite subscription because the bottle is on the shelf.
Three Groups Have No Safety Data At All
Every published trial recruited healthy adults, most of them over 40. Three groups were never enrolled, so there is no tolerability data to report for them:
✅ Pregnant or breastfeeding women — not studied, so not recommended
✅ Anyone under 18 — no trial has enrolled a minor
✅ People on prescription medication — no drug-interaction study has been published
That third one deserves a sentence of its own. Urolithin A has not been formally tested against common prescriptions, so nobody can tell you it is clear of interactions. If you take a blood thinner, a diabetes medication, an immunosuppressant, or anything with a narrow therapeutic window, the correct move is to ask the clinician who prescribed it before adding this. Same if you have kidney or liver disease — the compound is cleared through those systems, and no trial enrolled people whose clearance is impaired (D'Amico et al., Trends in Molecular Medicine, 2021).
The Label Is a Bigger Risk Than the Molecule
For most American shoppers the practical hazard is not a side effect. It is paying urolithin A prices for something that is not urolithin A.
Pomegranate extract and urolithin A are different products. Extract supplies ellagitannins, the raw material; your gut bacteria then have to convert them. Only a minority of people carry the microbiome that performs that conversion efficiently — the metabotype research puts reliable converters well under half the population (Tomás-Barberán et al., 2017). A bottle of pomegranate extract is a bet on a conversion most buyers cannot make.
Two label patterns are worth walking away from: a product that names "pomegranate extract" in the Supplement Facts panel while advertising urolithin A on the front, and a proprietary blend that hides the urolithin A milligrams inside a total. If the panel will not tell you the milligrams of urolithin A per serving, the panel is the answer.
What the Three Trials Actually Tested
Reading the trials side by side shows how narrow the tested territory really is, and where a US buyer is extrapolating rather than following data.
| Trial | Population | Daily dose | Duration | Tolerability reported |
|---|---|---|---|---|
| Andreux 2019, Nature Metabolism | Healthy adults 61–85 | 250 / 500 / 1,000 mg (single doses to 2,000 mg) | 4 weeks | Safe and well tolerated; no dose-limiting toxicity |
| Singh 2022, Cell Reports Medicine | 88 adults 40–64 | 500 / 1,000 mg | 4 months | Well tolerated; events similar to placebo |
| Liu 2022, JAMA Network Open | 66 adults 65–90 | 1,000 mg | 4 months | Well tolerated; events similar to placebo |
| Not studied | Under 18, pregnancy, breastfeeding, impaired kidney/liver | — | — | No data |
OUR VERDICT
For a healthy adult over 40, the published record on urolithin A is unusually quiet on side effects — mild digestive upset at worst, nothing serious at up to 1,000 mg daily for four months. The caution belongs on duration, on untested groups, and on labels that sell pomegranate extract as the finished compound.
How to Buy Urolithin A Safely in the US
American supplements are regulated as food, not drugs. The FDA does not approve a dietary supplement before it is sold, and a label may only make structure/function claims — "supports mitochondrial health" is allowed, "treats" or "prevents" anything is not. A US product making a disease claim is telling you it does not respect the rules it operates under.
Three checks do most of the work on a US label:
- The Supplement Facts panel names urolithin A directly, with milligrams per serving, not a proprietary blend and not pomegranate extract standing in for it.
- The serving matches the tested range. The human trials ran 250 to 1,000 mg, and 500 mg is the dose two of the three used. Anything advertising a fraction of that is not the trial dose.
- The purity is stated as a number. A percentage on the panel is a commitment; "premium quality" is a mood.
AgeAura Pure Urolithin A is the Urolithin A product Wellness Nest stocks, at $199.99 for 30 vegan capsules — 500 mg of ≥98% pure urolithin A per serving, which is the dose used in two of the three trials above. Category pricing in the US runs roughly $60 to $250 per month depending on whether you are buying the isolated compound or an extract standing next to it, and that spread is mostly the difference this article is about. The rest of the longevity line sits in the AgeAura collection, and the store's most-ordered products are grouped in Best Sellers.
If you are still deciding how much to take rather than whether to start, the dose-by-dose breakdown of what the trials used covers that ground.
See the full Supplement Facts panel →
Frequently Asked Questions
Does urolithin A cause stomach upset?
Mild digestive complaints — loose stools, light nausea, abdominal discomfort — are the side effects that appear most often in urolithin A trials, and they showed up at rates close to placebo. They tend to be limited to the first several days. Taking the capsule with a meal rather than on an empty stomach is the usual adjustment.
Is urolithin A safe to take every day?
In the published trials, adults took 500 to 1,000 mg daily for up to four months with no serious adverse events reported. Beyond four months there is no human safety data either way, so daily use past that window is an extrapolation rather than a documented result.
Who should not take urolithin A?
Anyone pregnant or breastfeeding, anyone under 18, and anyone with kidney or liver impairment — none of those groups were enrolled in a trial, so there is no tolerability data for them. Anyone on prescription medication should ask their prescriber first, because no drug-interaction study for urolithin A has been published.
Can I get urolithin A from pomegranate juice instead?
Only if your gut bacteria convert it, and most people's do not do so efficiently. Juice and extract supply ellagitannins, the precursor; the microbiome has to finish the job. Metabotype research puts reliable converters well under half the population, which is why a direct urolithin A capsule exists at all.
Where can I buy urolithin A in the US?
Wellness Nest ships AgeAura Pure Urolithin A across the United States from its own store, and the product page carries the current price and the full Supplement Facts panel. Buying from a store that publishes the panel — rather than from a marketplace listing that only shows marketing copy — is the simplest way to confirm you are getting the isolated compound at a stated milligram dose.
How long before urolithin A does anything?
The trials that measured muscle outcomes ran four months, and the changes they detected were measured at that point rather than in the first weeks. Treat it as a slow compound: the published evidence describes a multi-month timeline, not a same-week effect.
About the Author
Dr. Marcus Hale — Dr. Marcus Hale is the resident health researcher behind Wellness Nest's editorial team, translating peer-reviewed sports-nutrition and longevity research into practical daily guidance for US readers.
